Semaglutide
An ingredient in specific Health Canada-authorized prescription drugs; authorization never extends automatically to every product sold under the ingredient name.
Status checked August 2, 2026The evidence desk
Source-led reporting and practical explainers from PeptideInfo.ca.
An ingredient in specific Health Canada-authorized prescription drugs; authorization never extends automatically to every product sold under the ingredient name.
Status checked August 2, 2026A practical guide to DINs, product monographs, status fields, and the limits of a product-database search.
Status checked August 2, 2026Health Canada’s 2026 warning is explicit: research-use labelling is not a safety guarantee or a workaround for unauthorized injectable peptide drugs.
Status checked August 2, 2026BPC-157 is heavily promoted for recovery, but Canadian authorization and human evidence do not support the certainty common in online claims.
Status checked August 2, 2026The April 9, 2026 advisory names common unauthorized injectable peptides, rejects the research-use loophole, and gives Canadians concrete safety steps.
Status checked August 2, 2026An investigational 15-amino-acid peptide widely promoted for recovery despite very limited human evidence.
Status checked August 2, 2026An investigational analogue associated with growth-hormone signalling and sold online in unauthorized injectable products.
Status checked August 2, 2026A copper-binding peptide studied in skin and tissue biology; topical cosmetic discussion should not be confused with unauthorized injectable products.
Status checked August 2, 2026An investigational growth-hormone secretagogue promoted for body composition and recovery without an authorized Canadian drug product.
Status checked August 2, 2026A name used online for products related to thymosin beta-4, promoted for repair and recovery despite major evidence and product-identity gaps.
Status checked August 2, 2026